Gene · 90
Papers2,859
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,201 to 1,220 of 2,859
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
Association analysis of polymorphisms rs12997 in ACVR1 and rs1043784 in BMP6 genes involved in bone morphogenic protein signaling pathway in primary angle-closure and pseudoexfoliation glaucoma patients of Saudi origin. | BMC Med Genet | 2020 | 32641001 | PubTator, text mining | PubMed |
| Human Fibroblasts as a Model for the Study of Bone Disorders. | Front Endocrinol (Lausanne) | 2020 | 32636804 | PubTator, text mining | PubMed |
| Harmonization of postmortem donations for pediatric brain tumors and molecular characterization of diffuse midline gliomas. | Sci Rep | 2020 | 32616776 | PubTator, text mining | PubMed |
| Gemigliptin Inhibits Interleukin-1β-Induced Endothelial-Mesenchymal Transition via Canonical-Bone Morphogenetic Protein Pathway. | Endocrinol Metab (Seoul) | 2020 | 32615723 | PubTator, text mining | PubMed |
| Illuminating novel biological aspects and potential new therapeutic approaches for chronic myeloproliferative malignancies. | Hematol Oncol | 2020 | 32592408 | PubTator, text mining | PubMed |
| Heart‑lung crosstalk in pulmonary arterial hypertension following myocardial infarction (Review). | Int J Mol Med | 2020 | 32582962 | PubTator, text mining | PubMed |
| Pediatric Diffuse Midline Gliomas H3 K27M-Mutant and Non-Histone Mutant Midline High-Grade Gliomas in Neurofibromatosis Type 1 in Comparison With Non-Syndromic Children: A Single-Center Pilot Study. | Front Oncol | 2020 | 32582540 | PubTator, text mining | PubMed |
| Comprehensive Analysis of Key Genes and Regulatory Elements in Osteosarcoma Affected by Bone Matrix Mineral With Prognostic Values. | Front Genet | 2020 | 32582282 | PubTator, text mining | PubMed |
| Endothelial protective factors BMP9 and BMP10 inhibit CCL2 release by human vascular endothelial cells. | J Cell Sci | 2020 | 32576665 | PubTator, text mining | PubMed |
| The Role of Bone Morphogenetic Protein Signaling in Non-Alcoholic Fatty Liver Disease. | Sci Rep | 2020 | 32561790 | PubTator, text mining | PubMed |
| Cohen Syndrome Patient iPSC-Derived Neurospheres and Forebrain-Like Glutamatergic Neurons Reveal Reduced Proliferation of Neural Progenitor Cells and Altered Expression of Synapse Genes. | J Clin Med | 2020 | 32560273 | PubTator, text mining | PubMed |
| Pharmacokinetics and Pharmacodynamics of Garetosmab (Anti-Activin A): Results From a First-in-Human Phase 1 Study. | J Clin Pharmacol | 2020 | 32557665 | PubTator, text mining | PubMed |
| The integrated genomic and epigenomic landscape of brainstem glioma. | Nat Commun | 2020 | 32555164 | PubTator, text mining | PubMed |
| Novel venom-based peptides (P13 and its derivative-M6) to maintain self-renewal of human embryonic stem cells by activating FGF and TGFβ signaling pathways. | Stem Cell Res Ther | 2020 | 32552810 | PubTator, text mining | PubMed |
| Bone morphogenetic protein receptors: Structure, function and targeting by selective small molecule kinase inhibitors. | Bone | 2020 | 32522605 | PubTator, text mining | PubMed |
| Activin A forms a non-signaling complex with ACVR1 and type II Activin/BMP receptors via its finger 2 tip loop. | Elife | 2020 | 32515349 | PubTator, text mining | PubMed |
| The Prediction of miRNAs in SARS-CoV-2 Genomes: hsa-miR Databases Identify 7 Key miRs Linked to Host Responses and Virus Pathogenicity-Related KEGG Pathways Significant for Comorbidities. | Viruses | 2020 | 32512929 | PubTator, text mining | PubMed |
| Design of primers for direct sequencing of nine coding exons in the human ACVR1 gene. | Bone | 2020 | 32512165 | PubTator, text mining | PubMed |
| Receptor-interacting protein kinase 2 (RIPK2) and nucleotide-binding oligomerization domain (NOD) cell signaling inhibitors based on a 3,5-diphenyl-2-aminopyridine scaffold. | Eur J Med Chem | 2020 | 32505849 | PubTator, text mining | PubMed |
| Pediatric high-grade glioma: aberrant epigenetics and kinase signaling define emerging therapeutic opportunities. | J Neurooncol | 2020 | 32504402 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/90/papers?page=61